Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.61 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.61 |
| ▸ | GAPDH | P04406 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.50 |
| ▸ | ADH1B | P00325 | 1/20 | 0.47 |
| ▸ | ADH1C | P00326 | 1/20 | 0.47 |
| ▸ | ADH1A | P07327 | 1/20 | 0.47 |
| ▸ | ADH4 | P08319 | 1/20 | 0.47 |
| ▸ | ADH7 | P40394 | 1/20 | 0.47 |
| ▸ | FDPS | P14324 | 3/20 | 0.45 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5179720 | 1.00 | TRPA1 (0.61) | TRPA1DDAH1GAPDHMAPTGPR84 | |
| SCHEMBL7612717 | 1.00 | TRPA1 (0.61) | TRPA1DDAH1GAPDHMAPTGPR84 | |
| SCHEMBL5181161 | 1.00 | TRPA1 (0.61) | TRPA1DDAH1GAPDHMAPTGPR84 | |
| SCHEMBL4424265 | 1.00 | TRPA1 (0.61) | TRPA1DDAH1GAPDHMAPTGPR84 | |
| SCHEMBL4424172 | 1.00 | TRPA1 (0.61) | TRPA1DDAH1GAPDHMAPTGPR84 | |
| SCHEMBL23037444 | 1.00 | TRPA1 (0.61) | TRPA1DDAH1GAPDHMAPTGPR84 | |
| SCHEMBL4425883 | 1.00 | TRPA1 (0.61) | TRPA1DDAH1GAPDHMAPTGPR84 | |
| SCHEMBL7607320 | 1.00 | TRPA1 (0.61) | TRPA1DDAH1GAPDHMAPTGPR84 | |
| SCHEMBL3186133 | 1.00 | TRPA1 (0.61) | TRPA1DDAH1GAPDHMAPTGPR84 | |
| SCHEMBL3191386 | 1.00 | TRPA1 (0.61) | TRPA1DDAH1GAPDHMAPTGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238186-A1 | Topical Compositions Comprising (Glyco)Sphingolipids and/or (Glyco)Ceramides | CARBOCODE S.A. (PT) | 2024-07-18 | — | — | US | claimed |
| EP-4329718-A1 | TOPICAL COMPOSITIONS COMPRISING (GLYCO)SPHINGOLIPIDS AND/OR (GLYCO)CERAMIDES | CARBOCODE S.A. (PT) | 2024-03-06 | — | — | EP | claimed |
| WO-2024028834-A1 | REDUCTION OF SIGNS OF SKIN AGING | CARBOCODE S.A. (PT) | 2024-02-08 | — | — | WO | claimed |
| CN-117222396-A | Topical composition comprising (glycosyl) sphingolipids and/or (glycosyl) ceramides | 碳码股份公司 | 2023-12-12 | — | — | CN | claimed |
| WO-2023209655-A1 | SKIN CELL ENERGY BOOSTER COMPOSITION | CARBOCODE S.A. (PT) | 2023-11-02 | — | — | WO | claimed |
| EP-1511500-A4 | COMBINATION OF ANTI-MUSCARINIC AGENTS AND NON-GLUCOCORTICOID STEROIDS | EPIGENESIS PHARMACEUTICALS LLC (US) | 2009-04-29 | — | — | EP | claimed |
| JP-2006504666-A | — | — | 2006-02-09 | — | — | JP | claimed |
| EP-1511500-A2 | COMBINATION OF ANTI-MUSCARINIC AGENTS AND NON-GLUCOCORTICOID STEROIDS | Epigenesis Pharmaceuticals, Inc. (US) | 2005-03-09 | — | — | EP | claimed |
| WO-2004014293-A2 | COMBINATION OF ANTI-MUSCARINIC AGENTS AND NON-GLUCOCORTICOID STEROIDS | EPIGENESIS PHARMACEUTICALS, INC. (US) | 2004-02-19 | — | — | WO | claimed |
| US-20030216329-A1 | Composition, formulations & kit for treatment of respiratory & lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s) | EPEGENESIS PHARMACEUTICALS, INC. | 2003-11-20 | — | — | US | claimed |
| US-6284750-B1 | DRUG, COSMETICS STEROID | ESTEE LAUDER INC. | 2001-09-04 | — | — | US | claimed |
| EP-0876391-B1 | NOVEL STEROID ESTERS USEFUL AGAINST SKIN DISORDERS | ESTEE LAUDER INC (US) | 2000-08-16 | — | — | EP | claimed |
| US-6025347-A | Steroid esters useful against skin disorders | ESTEE LAUDER INC. (US) | 2000-02-15 | — | — | US | claimed |
| US-5948418-A | MERCAPTANS | ESTEE LAUDER, INC. (US) | 1999-09-07 | — | — | US | claimed |
| EP-0876391-A4 | NOVEL STEROID ESTERS USEFUL AGAINST SKIN DISORDERS | ESTEE LAUDER INC (US) | 1998-12-30 | — | — | EP | claimed |
| EP-0876391-A1 | NOVEL STEROID ESTERS USEFUL AGAINST SKIN DISORDERS | ESTEE LAUDER INC. (US) | 1998-11-11 | — | — | EP | claimed |
| US-5683705-A | Sulfur-based amides and bis-amides useful against skin disorders | ESTEE LAUDER, INC. (US) | 1997-11-04 | — | — | US | claimed |
| WO-1997010255-A1 | NOVEL STEROID ESTERS USEFUL AGAINST SKIN DISORDERS | ESTEE LAUDER, INC. (US) | 1997-03-20 | — | — | WO | claimed |
| US-20240238186-A1 | Topical Compositions Comprising (Glyco)Sphingolipids and/or (Glyco)Ceramides | CARBOCODE S.A. (PT) | 2024-07-18 | — | — | US | disclosed |
| WO-1997010255-A1 | NOVEL STEROID ESTERS USEFUL AGAINST SKIN DISORDERS | ESTEE LAUDER, INC. (US) | 1997-03-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238186-A1 | Topical Compositions Comprising (Glyco)Sphingolipids and/or (Glyco)Ceramides | UGCG, CERT1, CERS2 | TRPA1 3528/4885DDAH1 3519/4885GAPDH 1045/4885 |
| US-20030216329-A1 | Composition, formulations & kit for treatment of respiratory & lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s) | KIT, NR5A1, CHRM5 | TRPA1 4747/4885DDAH1 1929/4885GAPDH 1346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.